~26 spots leftby Jan 2026

LY3457263 + Dulaglutide for Type 2 Diabetes

Palo Alto (17 mi)
Age: 18+
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: Phase 1
Waitlist Available
Sponsor: Eli Lilly and Company

Trial Summary

What is the purpose of this trial?This trial is testing a new drug called LY3457263, alone or with another diabetes medication, in people with type 2 diabetes. Researchers will use blood tests to check if the drug is safe and how it affects the body.

Eligibility Criteria

Treatment Details

4Treatment groups
Experimental Treatment
Placebo Group
Group I: Placebo + DulaglutideExperimental Treatment2 Interventions
Placebo in combination with dulaglutide administered SC.
Group II: LY3457263 + DulaglutideExperimental Treatment2 Interventions
LY3457263 in combination with dulaglutide administered SC.
Group III: LY3457263 (Alone)Experimental Treatment1 Intervention
LY3457263 administered subcutaneously (SC).
Group IV: Placebo (Alone)Placebo Group1 Intervention
Placebo administered SC.

Find a clinic near you

Research locations nearbySelect from list below to view details:
Atlanta Center of Medical ResearchAtlanta, GA
Pinnacle Research Group, LLCAnniston, AL
Hassman Research InstituteBerlin, NJ
CenExcel ACTAnaheim, CA
More Trial Locations
Loading ...

Who is running the clinical trial?

Eli Lilly and CompanyLead Sponsor

References